Skip to content

Overview

Chinese mining companies jointly donate anti-epidemic materials to Peruvian Ministry of Health in January 2021

Commitments (Constant USD, 2023)$183,387
Commitment Year2021Country of ActivityPeruDirect Recipient Country of IncorporationPeruSectorHealthFlow TypeGrant

Status

Project lifecycle

Completion

Pipeline: PledgePipeline: CommitmentImplementationCompletion

Timeline

Key dates

Commitment date
Jan 27, 2021
Start (actual)
Jan 27, 2021
End (actual)
Jan 27, 2021

Stakeholders

Organizations involved in projects and activities supported by financial and in-kind transfers from Chinese government and state-owned entities

Funding agencies

State-owned companies

  • Aluminum Corporation of China (Chinalco)
  • China Minmetals Corporation (CMC)
  • Shougang Group

Cofinancing agencies

Private Sector

  • Zhongrong Xinda Group Co., Ltd

Receiving agencies

Government Agencies

  • Peru Ministry of Health (Ministerio de Salud) (MINSA)

Implementing agencies

Government Agencies

  • Chinese Embassy

State-owned companies

  • China National Pharmaceutical Group Corporation (Sinopharm)

Loan description

Chinese mining companies jointly donate anti-epidemic materials to Peruvian Ministry of Health in January 2021

Narrative

Full Description

Project narrative

On January 27, 2021, a few Chinese mining companies jointly donated anti-epidemic materials to the Peruvian Ministry of Health. The companies participating in this donation are Minmetals, Shougang, Chinalco, and Zhongrong Xinda. The donated materials included 20 portable oxygen concentrators, 10 Bilevel PAP System ventilators, and 7 emergency ventilators. The purpose of this donation is to support Peru’s COVID-19 response efforts. The Chinese Embassy in Peru and Sinopharm, a Chinese pharmaceutical company, helped coordinate the delivery of these materials to Peru.

Staff comments

1. AidData has estimated the transaction amount for this donation based on price catalogues from the World Health Organization (WHO). Please see the TUFF Methodology for additional details.